SEATTLE, Aug. 16 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) will host a conference call today (Thursday, August 16) at 8:30 a.m. Eastern to discuss the acquisition of Zevalin from Biogen Idec. The conference call and slides will be web cast live and archived approximately two hours after the conference call ends.
Conference Call Numbers Thursday, August 16 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific 866-249-6463 303-262-2211 Webcast and slides available at http://www.cticseattle.com -- webcast will be archived approximately two hours after call ends. Call-back numbers for post listening available at 10:00 am Eastern 800-405-2236 303-590-3000 Passcode: 11095845 Media Contact: Dan Eramian T: 206.272.4343 C: 206.854.1200 Susan Callahan T: 206.272.4472 F: 206.272.4434 E: media@ctiseattle.comhttp://www.cticseattle.com/media.htm Investors Contact: Leah Grant T: 206.282.7100 F: 206.272.4434 E: invest@ctiseattle.comhttp://www.cticseattle.com/investors.htm
Cell Therapeutics, Inc.CONTACT: Media, Dan Eramian , +1-206-272-4343, cell, +1-206-854-1200, orSusan Callahan, +1-206-272-4472, media@ctiseattle.com, Investors, LeahGrant, +1-206-282-7100, invest@ctiseattle.com, all of Cell Therapeutics,Inc., fax, +1-206-272-4434
Web site: http://www.cticseattle.com//
